ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

DRMA Dermata Therapeutics Inc

0.3397
0.00 (0.00%)
Pre Market
Last Updated: 04:44:02
Delayed by 15 minutes

Dermata Therapeutics Financial Summary

The current DRMA market cap is 1.08M. The company's latest EPS is USD -2.4443 and P/E is -0.14.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -2.45M-1.71M-2.28M-1.73M-1.81M
Net Income -2.42M-1.67M-2.24M-1.7M-1.72M
Year End December 30 2023 2020202120222023
USD ($)USD ($)USD ($)USD ($)
Total Revenue 0000
Operating Income -3.17M-7.86M-9.67M-8.04M
Net Income -3.24M-7.9M-9.61M-7.8M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)
Total Assets 8.98M6.94M9.3M8.71M7.32M
Total Liabilities 1.51M922k1.21M683k916k
Total Equity 7.47M6.02M8.09M8.03M6.41M
Year End December 30 2023 2020202120222023
USD ($)USD ($)USD ($)USD ($)
Total Assets 605k11.62M6.94M7.98M
Total Liabilities 3.78M1.52M922k1.62M
Total Equity -3.18M10.11M6.02M6.36M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)
Operating -7.01M-8.83M-1.65M-3.49M-5.26M
Investing N/A N/A N/A N/A N/A
Financing 4.28M4.28M4.18M5.69M5.65M
Year End December 30 2023 2020202120222023
USD ($)USD ($)USD ($)USD ($)
Operating -4.03M-5.69M-8.83M-6.41M
Investing N/A N/A N/A N/A
Financing 2.57M15.96M4.28M7.61M
Market Cap 1.08M
Price to Earnings Ratio -0.14
Price to Sales Ratio 0
Price to Cash Ratio 0.15
Price to Book Ratio 0.17
Dividend Yield -

Share Statistics

Shares Outstanding 3.19M
Average Volume (1 week) 99.28k
Average Volume (1 Month) 195.71k
52 Week Change -86.68%
52 Week High 3.68
52 Week Low 0.232
Spread (Intraday) 0.04 (10.61%)

Company Info

Company Name Dermata Therapeutics Inc
Address 251 little falls drive
wilmington, delaware 19808
Website https://www.dermatarx.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock